Skip to main content

Advertisement

Table 3 Effect of intervention on primary and secondary endpoints

From: Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial

Outcomes 3-Day Routine Change
Group
(n = 177)
Clinically Indicated Change Group
(n = 185)
RR (95% CI),
PValue
Primary:    
IVD complications per patient, n (%) 64 (36%) 76 (41%) RR 1.14 (0.88, 1.47),
p = 0.39
IVD complications per 1000 IVD days 66.0
(95% CI 49.8, 82.1)
67.8
(95% CI 52.6, 83.1)
HR 1.03 (0.74, 1.43),
p = 0.86
Secondary:    
Phlebitis, n (%) 12 (7%) 18 (10%) RR 1.44 (0.71, 2.89), p = 0.34
Infiltration, n (%) 53 (30%) 61 (33%) RR 1.10 (0.81, 1.49), p = 0.57
Occlusion, n (%) 5 (3%) 4 (2%) RR 0.77 (0.21, 2.80), p = 0.75
Accidental removal, n (%) 11 (6%) 16 (9%) RR 1.39 (0.66, 2.92), p = 0.43
Local infection 0 0 -
IVD-related BSI, n (%) 0 0 -
IVD costs per patient,
AUD$ mean (SD)
$55.42 ($35.26) $43.35
($26.78)
Mean difference
$12.07 (95%CI $5.57, $18.56), p < 0.001